Red blood cell acetylcholinesterase and plasma butyrylcholinesterase status: Important indicators for the treatment of patients poisoned by organophosphorus compounds

Arhiv za Higijenu Rada i Toksikologiju

Volumn 58, Issue 3, 2007, Pages 359-366

  Thiermann, Horst ^a   Kehe, Kai ^a   Steinritz, Dirk ^a   Mikler, John ^b   Hill, Ira ^b   Zilker, Thomas ^c   Eyer, Peter ^d   Worek, Franz ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Human poisoning; Nerve agents; Neuromuscular transmission; Oxime therapy; Pesticides

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; CHOLINESTERASE; DIAZEPAM; ERYTHROCYTE ENZYME; MUSCARINIC RECEPTOR; OBIDOXIME; ORGANOPHOSPHORUS COMPOUND; OXIME DERIVATIVE; PRALIDOXIME; SARIN;

BLOOD SAMPLING; BRONCHOSPASM; BRONCHUS SECRETION; CONVULSION; DRUG INTOXICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; LOADING DRUG DOSE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; ORGANOPHOSPHORUS INTOXICATION; RESPIRATION DEPRESSION; RESPIRATORY FAILURE; REVIEW; SWINE;

ACETYLCHOLINESTERASE; ANIMALS; BIOLOGICAL MARKERS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE REACTIVATORS; ERYTHROCYTES; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; POISONING; SWINE;

SUIDAE;

EID: 35148893731     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10004-007-0030-6     Document Type: Review

References (46)

1. Tu AT. Chemical terrorism: horrors in Tokyo subway and Matsumoto city. Fort Collins: Alaken Inc.; 2002.
2. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003;22:165-90.
3. nd ed. San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo: Academic Press; 2001. p. 1043-85.
4. th ed. Norwalk, Connecticut: Appleton & Lange; 1994. p. 1105-16.
5. Eddleston M, Buckley NA, Checketts H, Senarathna L, Mohamed F, Sheriff MH, Dawson A. Speed of initial atropinisation in significant organophosphorus pesticide poisoning - a systematic comparison of recommended regimens. J Toxicol Clin Toxicol 2004;42:865-75.
6. Wilson IB, Ginsburg S. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochem Biophys Acta 1955;18:168-70.
7. Namba T, Hiraki K. PAM (Pyridine-2-aldoxime methiodide) therapy for alkylphosphate poisoning. JAMA 1958;166:1834-9.
8. Erdmann WD, Clarmann M. Ein neuer Esterase-Reaktivator für die Behandlung von Vergiftungen mit Alkylphosphaten [A new esterase reactivator for the treatment of alkylphosphate poisoning, in German]. Deutsch Med Wochenschr 1963;45:2201-7.
9. Sundwall A. Minimum concentrations of Nmethylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block. Biochem Pharmacol 1961;8:413-7.
10. Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004;68:2237-48.
11. Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999;107:233-9.
12. Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002;76:523-9.
13. Eyer P. Optimal oxime dosage regimen, a pharmacokinetic approach. In: Szinicz L, Eyer P, Klimmek R, editors. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning.Heidelberg. Berlin, Oxford: Spektrum Akademischer Verlag; 1996. p. 33-51.
14. Eyer P. Use of obidoxime in OP poisoning. Hum Exp Toxicol 1996;15:78.
15. Eyer P, Szinicz L, Thiermann H, Worek F, Zilker T. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality. Toxicology 2007;233:108-19.
16. Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 1997;16:473-80.
17. Worek F, Baecker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 1997;16:466-72.
18. Worek F, Szinicz L, Eyer P, Thiermann H. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model. Toxicol Appl Pharmacol 2005;209:193-202.
19. Worek F, Eyer P, Szinicz L, Thiermann H. Simulation of cholinesterase status at different scenarios of nerve agent exposure. Toxicology 2007;233:155-65.
20. Thiermann H, Szinicz L, Eyer P, Felgenhauer N, Zilker T, Worek F. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning. Toxicology 2007;233:145-54.
21. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006;368:2136-41.
22. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999;288:73-90.
23. Thiermann H, Szinicz L, Eyer P, Zilker T, Worek F. Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning. Chem Biol Interact 2005;157-158:345-7.
24. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005;366:1452-9.
25. Pfeiffer B. Vergiftungen durch Organophosphate I. MTA Dialog 2005;6:583-5.
26. Pfeiffer B. Analyzing cholinesterase in organophosphate poisoning. Tecan J 2006;2:22-3.
27. Eberly JP, Eyer P, Pfeiffer B, Szincz L, Worek F. Modification of the Test-mate ChE cholinesterase test system for use over an extended temperature range. Medical Defense Bioscience Review 2004;1-11.
28. Eyer F, Meischner V, Kiderlen D, Thiermann H, Worek F, Haberkorn M, Flegenhauer N, Zilker T, Eyer P. Human parathion poisoning. Toxicol Rev 2003;22:143-63.
29. Eyer F, Eyer P. Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients. Hum Exp Toxicol 1998;17:645-51.
30. Wolthuis O, Vanwersch RA, van der Wiel HJ. The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Eur J Pharmacol 1981;70:355-69.
31. Smith AP, van der Weil HJ, Wolthuis OL. Analysis of oxime-induced neuromuscular recovery in guinea-pig, rat and man following soman poisoning in vitro. Eur J Pharmacol 1981;70:371-9.
32. van der Meer C, Wolthuis OL. The effect of oximes on isolated organs intoxicated with organophosphorus anticholinesterases. Biochem Pharmacol 1965;14:1299-312.
33. van Helden HP, van der Wiel HJ, Wolthuis OL. Retention of soman in rats, guinea-pigs and marmosets: speciesdependent effects of the soman simulator, pinacolyl dimethylphosphinate (PDP). J Pharm Pharmacol 1988;40:35-41.
34. van Helden HP, van der Wiel HJ, de Lange J, Busker RW, Melchers BP, Wolthuis OL. Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol Appl Pharmacol 1992;115:50-6.
35. Alberts P. A new H-oxime restores rat diaphragm contractility after esterase inhibition in vitro. Eur J Pharmacol 1990;184:191-4.
36. Thiermann H, Eyer P, Worek F, Szinicz L. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon. Toxicol 2005;214:190.
37. Maselli RA, Leung C. Analysis of anticholinesterase-induced neuromuscular transmission failure. Muscle Nerve 1993;16:548-53.
38. Besser R, Gutmann L, Dillmann U, Weilemann LS, Hopf HC. End-plate dysfunction in acute organophosphate intoxication. Neurology 1989;39:561-7.
39. Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993;41:31-91.
40. Brimijoin S. Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol 1983;21:291-322.
41. Mortensen SR, Brimijoin S, Hooper MJ, Padilla S. Comparison of the in vitro sensivitiy of rat acetylcholinesterase to chlorpyrifos-oxon: What do tissue IC50 values represent? Toxicol Appl Pharmacol 1998;148:46-9.
42. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971;50:475-92.
43. Brank M, Zajc-Kreft K, Kreft S, Komel R, Grubic Z. Biogenesis of acetylcholinesterase is impaired, although its mRNA level remains normal, in the glucocorticoid-treated rat skeletal muscle. Eur J Biochem 1998;251:374-81.
44. Grubic Z, Sketelj J, Klinar B, Brzin M. Recovery of acetylcholinesterase in the diaphragm, brain, and plasma of the rat after irreversible inhibition by soman: a study of cytochemical localization and molecular forms of the enzyme in the motor end plate. J Neurochem 1981;37:909-16.
45. Worek F, Eyer P, Szinicz L. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 1998;72:580-7.
46. Spöhrer U, Eyer P. Separation of geometrical syn and anti isomers of obidoxime by ion-pair high-performance liquid chromatography. J Chromatogr A 1995;693:55-61.